GiiAnt, the Gastrointestinal-induced Anti-inflammatory technology, is a unique local delivery strategy that aims at maximizing the therapeutic effect at the site of inflammation while minimizing any potential side effects from systemic exposure.

Potent anti-inflammatory agents have been engineered as a prodrug to target only the colonic area. In this system, the colon-specific carrier covalently bound to the active moiety is enzymatically cleaved off locally by the large intestine microbiota.